Astex Technology, the Fragment-Based Drug Discovery and Development Company, Today Announced Issuance of Patent GB2395718 Covering the Use of the Crystal Structure of Human Cytochrome P450 3A4, the Most Important Drug Metabolising Enzyme in Man

| Quelle: Astex Therapeutics Astex Therapeutics

CAMBRIDGE, United Kingdom, Jan. 24, 2005 (PRIMEZONE) -- Astex Technology:

Full press release attached below: http://hugin.info/132636/R/976983/143988.pdf 


            








        

            

                

                    
Tags

                            
                                INTERNATIONAL
                            
                            
                                HEALTH
                            

                



        




    

        

        
Kontaktdaten